Promis Neurosciences INC DEF 14A proxy statements

ProMIS Neurosciences Inc. has announced its 2026 Annual Meeting of Shareholders will be held virtually on May 20, 2026, to elect directors, ratify auditors, and approve a stock plan amendment.

PROMIS Neurosciences Inc. will hold a Special Meeting on November 17, 2025, to vote on a share consolidation proposal ranging from one-for-five to one-for-twenty-five.

ProMIS Neurosciences Inc. will hold a Special Meeting on November 17, 2025, for shareholders to vote on a share consolidation to meet Nasdaq's minimum bid price requirement.

Promis Neurosciences Inc. will hold its annual shareholder meeting on June 12, 2025, with voting open until June 10, 2025, to elect directors, ratify the appointment of auditors, and approve the 2025 Stock Option and Incentive Plan.

ProMIS Neurosciences announces its 2025 Annual Meeting of Shareholders to be held virtually on June 12, 2025, featuring proposals for director elections, auditor ratification, and approval of a new stock option and incentive plan.

Promis Neurosciences Inc. is holding a special meeting on October 23, 2024, for shareholders to vote on a proposal related to the issuance of common shares and a potential adjournment of the meeting.

ProMIS Neurosciences is holding a special meeting to seek shareholder approval for the potential issuance of common shares underlying warrants from a recent private placement, as required by Nasdaq listing rules.

Promis Neurosciences Inc. has scheduled its 2024 Annual Meeting for June 13, 2024, and is providing proxy materials to shareholders for voting on key proposals.

ProMIS Neurosciences will hold its 2024 Annual Meeting of Shareholders virtually on June 13, 2024, to vote on director elections, appointment of auditors, and other corporate matters.